- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有42家主力机构披露2025-06-30报告期持股数据，持仓量总计2.09亿股，占流通A股35.45%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了58%的股票
技术面评分前10的股票
近期的平均成本为5.64元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为5.64元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.64","date":1762141961,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.11.03","stock":"1.97","trade":"0.04","ind":"0.19"},{"date":"2025.10.31","stock":"1.83","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-2.50","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"-1.41","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"1.25","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"0.36","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"-2.27","trade":"0.39","ind":"2.02"},{"date":"2025.10.23","stock":"-0.87","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"2.66","trade":"-0.28","ind":"-0.62"},{"date":"2025.10.21","stock":"1.08","trade":"1.45","ind":"2.06"},{"date":"2025.10.20","stock":"2.01","trade":"0.44","ind":"0.98"},{"date":"2025.10.17","stock":"-2.15","trade":"-1.55","ind":"-3.04"},{"date":"2025.10.16","stock":"-0.18","trade":"0.01","ind":"-0.25"},{"date":"2025.10.15","stock":"1.27","trade":"2.13","ind":"1.73"},{"date":"2025.10.14","stock":"-1.78","trade":"-1.02","ind":"-2.54"},{"date":"2025.10.13","stock":"0.90","trade":"-1.02","ind":"-0.93"},{"date":"2025.10.10","stock":"2.01","trade":"-0.88","ind":"-2.70"},{"date":"2025.10.09","stock":"0.92","trade":"-0.38","ind":"1.47"},{"date":"2025.09.30","stock":"-0.18","trade":"0.69","ind":"0.35"},{"date":"2025.09.29","stock":"0.93","trade":"0.77","ind":"2.05"},{"date":"2025.09.26","stock":"0.19","trade":"-1.00","ind":"-1.76"}]
东宝生物,深证成指,生物制品指数
压力支撑
该股压力位为5.62元，支撑位为5.55元。
[{"text":"\u538b\u529b\u4f4d","value":"5.62","date":1762099200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.55","date":1762099200,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了49%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月04日 12:51
| 机构今日流向(万元) | -658.10 | 机构5日流向(万元) | 2903.61 |
| 机构10日流向(万元) | -764.79 | 机构20日流向(万元) | -8928.15 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加335.59万股，其中基金净减仓7家，主力净增仓7家，请投资者中长期谨慎为宜。
截止2025-06-30，共42家主力机构（基金36家，一般法人4家，社保基金1家，信托公司1家），持仓量总计20908.57万股，占流通A股35.45%
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 0.67万股
减仓：9家 ，减持 34.11万股
新出现在主力名单中：24家 ，持有111.74万股
从主力名单中消失：17家 ，原持有82.36万股
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 0.67万股
减仓：9家 ，减持 34.11万股
新出现在主力名单中：24家 ，持有111.74万股
从主力名单中消失：17家 ，原持有82.36万股
消息面诊股
诊断结果：5.5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 股东追踪|广发聚丰混合A新进东宝生物前十大流通股东
2025-10-29 - 东宝生物：第三季度净利润1148.22万元，同比下
2025-10-28 - 东宝生物：公司明胶产品未用于丰胸领域
2025-10-24 - 东宝生物：公司代血浆明胶（药典二部明胶）已经实现销
2025-10-24 - 美股“人造肉第一股”收涨近1.5倍 A股人造肉板块
2025-10-22 - 人造肉概念股盘初拉升，双塔食品涨停
2025-10-22 - 东宝生物：不向下修正“东宝转债”转股价格
2025-10-15 - 东宝生物：公司副总经理王刚与王富荣不存在亲属关系
2025-10-13 - 东宝生物：公司未向骨胶水生产厂家供应原料
2025-09-17 - 研判2025！中国胶原蛋白食品行业产业链、市场规模
2025-09-12
消息列表
| 一般消息 | 募资投向 | 2025-09-23 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-05-15 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-24 |
| 利好 | 分红转增 | 10派0.25元(含税) | 2025-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-24 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-02-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.0行业面打败了92%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2025.11.03","price":"0.19","value":"0.04"},{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.62","value":"-0.28"},{"date":"2025.10.21","price":"2.06","value":"1.45"},{"date":"2025.10.20","price":"0.98","value":"0.44"},{"date":"2025.10.17","price":"-3.04","value":"-1.55"},{"date":"2025.10.16","price":"-0.25","value":"0.01"},{"date":"2025.10.15","price":"1.73","value":"2.13"},{"date":"2025.10.14","price":"-2.54","value":"-1.02"},{"date":"2025.10.13","price":"-0.93","value":"-1.02"},{"date":"2025.10.10","price":"-2.70","value":"-0.88"},{"date":"2025.10.09","price":"1.47","value":"-0.38"},{"date":"2025.09.30","price":"0.35","value":"0.69"},{"date":"2025.09.29","price":"2.05","value":"0.77"},{"date":"2025.09.26","price":"-1.76","value":"-1.00"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 三生国健 | 40.63% | 41.90% | 6.2分 |
| 2 | 华兰疫苗 | 28.50% | 7.93% | 5.2分 |
| 3 | 我武生物 | 25.13% | 6.11% | 5.7分 |
| 4 | - | 17.79% | 6.82% | 分 |
| 5 | 万泽股份 | 14.40% | 7.63% | 6.5分 |
| 6 | 通化东宝 | 13.19% | 3.34% | 6.9分 |
| 8 | 金迪克 | 11.92% | 3.16% | 5.7分 |
| 10 | 赛升药业 | 10.18% | 5.06% | 5.3分 |
| 12 | 安科生物 | 8.89% | 6.86% | 6.5分 |
| 14 | 科兴制药 | 7.10% | 7.55% | 6.3分 |
| 16 | 昊帆生物 | 6.35% | 6.43% | 5.9分 |
| 18 | 优宁维 | 5.97% | 2.47% | 5.6分 |
| 20 | 东宝生物 | 5.77% | 1.07% | 5.7分 |
| 22 | 义翘神州 | 5.27% | 2.00% | 5.0分 |
| 24 | - | 5.02% | 6.24% | 分 |
| 26 | 博晖创新 | 4.30% | 2.11% | 5.6分 |
| 28 | 华兰生物 | 3.86% | 0.06% | 5.7分 |
| 30 | 卫光生物 | 3.05% | 0.59% | 5.2分 |
| 32 | 康希诺 | 2.68% | 5.15% | 6.2分 |
| 34 | 成大生物 | 1.66% | 0.73% | 5.1分 |
| 36 | ST未名 | 1.36% | 10.36% | 5.3分 |
| 38 | 智飞生物 | 0.00% | 2.42% | 5.7分 |
| 40 | 神州细胞 | -0.71% | 3.61% | 5.4分 |
| 42 | 天坛生物 | -2.89% | -1.60% | 5.5分 |
| 44 | 智翔金泰 | -3.32% | 1.46% | 5.2分 |
| 46 | 百奥泰 | -5.69% | -0.84% | 5.1分 |
| 48 | 荣昌生物 | -6.76% | 4.38% | 6.2分 |
| 50 | 特宝生物 | -8.09% | 6.18% | 5.6分 |
| 52 | 诺诚健华 | -12.83% | 5.60% | 5.7分 |
| 54 | 长春高新 | -14.71% | -6.82% | 5.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 26/72 ， 48/72。
[{"date":"2025-09-30","value":"2.80","vol":"-9.95"},{"date":"2025-06-30","value":"2.15","vol":"-0.61"},{"date":"2025-03-31","value":"1.10","vol":"0.46"},{"date":"2024-12-31","value":"5.06","vol":"-0.68"},{"date":"2024-09-30","value":"3.92","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.80 | 2.15 | 1.10 | 5.06 | 3.92 |
| 行业(%) | -9.95 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"24.53","vol":"67.19"},{"date":"2025-06-30","value":"25.44","vol":"68.28"},{"date":"2025-03-31","value":"25.06","vol":"68.43"},{"date":"2024-12-31","value":"22.72","vol":"69.85"},{"date":"2024-09-30","value":"22.62","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
24.53 | 25.44 | 25.06 | 22.72 | 22.62 |
| 行业(%) | 67.19 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 44/72 ， 35/72。
[{"date":"2025-09-30","value":"-15.84","vol":"44.96"},{"date":"2025-06-30","value":"-16.93","vol":"6902.04"},{"date":"2025-03-31","value":"-22.23","vol":"6125.27"},{"date":"2024-12-31","value":"-9.19","vol":"47.35"},{"date":"2024-09-30","value":"-13.82","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-15.84 | -16.93 | -22.23 | -9.19 | -13.82 |
| 行业(%) | 44.96 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-26.89","vol":"44.17"},{"date":"2025-06-30","value":"-28.00","vol":"5.44"},{"date":"2025-03-31","value":"-26.64","vol":"-8.46"},{"date":"2024-12-31","value":"-28.28","vol":"-9.81"},{"date":"2024-09-30","value":"-30.43","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-26.89 | -28.00 | -26.64 | -28.28 | -30.43 |
| 行业(%) | 44.17 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 22/72 ， 11/72。
[{"date":"2025-09-30","value":"0.21","vol":"0.22"},{"date":"2025-06-30","value":"0.14","vol":"0.14"},{"date":"2025-03-31","value":"0.07","vol":"0.06"},{"date":"2024-12-31","value":"0.33","vol":"0.29"},{"date":"2024-09-30","value":"0.23","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.14 | 0.07 | 0.33 | 0.23 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.04","vol":"0.91"},{"date":"2025-06-30","value":"0.74","vol":"0.56"},{"date":"2025-03-31","value":"0.39","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"},{"date":"2024-09-30","value":"1.48","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.04 | 0.74 | 0.39 | 2.15 | 1.48 |
| 行业(次) | 0.91 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"6.79","vol":"1.99"},{"date":"2025-06-30","value":"48.52","vol":"-1377.61"},{"date":"2025-03-31","value":"-19.96","vol":"-46.99"},{"date":"2024-12-31","value":"15.83","vol":"-11.33"},{"date":"2024-09-30","value":"-16.35","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.79 | 48.52 | -19.96 | 15.83 | -16.35 |
| 行业 | 1.99 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.60","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.60 | - | 0.88 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 36/72 ， 34/72。
[{"date":"2025-09-30","value":"4.90","vol":"5.99"},{"date":"2025-06-30","value":"4.37","vol":"6.64"},{"date":"2025-03-31","value":"4.49","vol":"7.75"},{"date":"2024-12-31","value":"3.81","vol":"6.72"},{"date":"2024-09-30","value":"3.00","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.90 | 4.37 | 4.49 | 3.81 | 3.00 |
| 行业 | 5.99 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.07","vol":"4.82"},{"date":"2025-06-30","value":"2.87","vol":"5.30"},{"date":"2025-03-31","value":"3.06","vol":"6.35"},{"date":"2024-12-31","value":"2.68","vol":"5.40"},{"date":"2024-09-30","value":"2.10","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.07 | 2.87 | 3.06 | 2.68 | 2.10 |
| 行业 | 4.82 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 14/72 ， 19/72。
[{"date":"2025-09-30","value":"32.50","vol":"28.14"},{"date":"2025-06-30","value":"33.79","vol":"26.73"},{"date":"2025-03-31","value":"33.71","vol":"26.03"},{"date":"2024-12-31","value":"33.73","vol":"25.81"},{"date":"2024-09-30","value":"36.68","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.50 | 33.79 | 33.71 | 33.73 | 36.68 |
| 行业(%) | 28.14 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.48","vol":"0.58"},{"date":"2025-06-30","value":"0.51","vol":"1.11"},{"date":"2025-03-31","value":"0.51","vol":"0.78"},{"date":"2024-12-31","value":"0.51","vol":"0.87"},{"date":"2024-09-30","value":"0.58","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.48 | 0.51 | 0.51 | 0.51 | 0.58 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.36","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]